|
Outcomes of Telepharmacy Services Combined with Medication Delivery by Mail in Breast Cancer Patients |
|---|---|
| รหัสดีโอไอ | |
| Creator | Jintana Tangsitchanakul |
| Title | Outcomes of Telepharmacy Services Combined with Medication Delivery by Mail in Breast Cancer Patients |
| Contributor | Pakorn Vorasin, Natchanaporn Pimpaka |
| Publisher | Faculty of Pharmaceutical Sciences KKU MSU UBU |
| Publication Year | 2569 |
| Journal Title | Isan Journal of Pharmaceutical Sciences |
| Journal Vol. | 22 |
| Journal No. | 1 |
| Page no. | 22-32 |
| Keyword | Telepharmacy, Breast cancer, Endocrine therapy, Medication adherence, Economic savings |
| URL Website | https://tci-thaijo.org/index.php/IJPS |
| Website title | Isan Journal of Pharmaceutical Sciences, IJPS |
| ISSN | 19050852 |
| Abstract | Medication knowledge and continuity of endocrine therapy are critical determinants of treatment outcomes in breast cancer. The integration of telepharmacy services with mailed medication delivery has been proposed as a strategy to enhance access to pharmaceutical care and mitigate travel-related barriers. Objective: To evaluate medication knowledge, drug-related problems (DRPs), medication adherence, patient satisfaction, and economic savings resulting from the integration of telepharmacy services and mail-order medication among breast cancer patients receiving endocrine therapy. Methods: A prospective quasi-experimental study was conducted at Khon Kaen Hospital from March 31 to December 31, 2025. Eighty-five patients receiving endocrine therapy were enrolled in a telepharmacy program integrated with mail medication delivery under the Medically Integrated Dispensing (MID) framework. Medication knowledge was assessed using a five-item structured test. Medication adherence was quantified using the Modified Medication Possession Ratio (mMPR). Patient satisfaction was evaluated using a five-point Likert scale, and travel-related expenditures were recorded. The Wilcoxon signed-rank test and descriptive statistics were used to analyze the data, with a two-tailed significance level set at p<0.05. Results: All participants were female (n = 85), with a mean age of 58.11 ± 9.72 years. Tamoxifen was the most frequently prescribed medication (57.65%). Post-program analysis demonstrated a statistically significant increase in median knowledge scores, from 4 to 5 (p< 0.05). DRPs were identified in 41.18% of patients, with hot flashes being the most common reported issue (24.71%). Mean mMPR was 97.36%, exceeding the predefined adherence threshold of 80%. Satisfaction scores were consistently high (mean range: 4.65–4.88). The intervention was associated with a mean reduction in travel costs of 496.06 ± 431.52 THB per visit. Conclusion: The integration of telepharmacy services with mailed medication delivery was associated with improved medication knowledge, high levels of adherence, high patient satisfaction, and reduced travel-related financial burden among breast cancer patients receiving endocrine therapy. |
